Bio-Gene Technology Limited (ASX:BGT)

Richard Jagger
MD & CEO
Market Cap (AUD): 21.23M
Sector: Materials
Last Trade (AUD): 0.135 +-0 (+-3.57%)
Tab Bar

1. About

Bio-Gene Technology Limited (ASX:BGT) is an Australian agtech company enabling the next generation of novel insecticides. 

Bio-Gene's novel platform technology is based on naturally occurring beta-triketones, a type of chemistry that may offer new solutions for insect management control in crop protection, public health and animal health.

The Company is developing two products targeted at different sectors of the insecticide market:

  • Flavocide, a chemically synthesised product based on flavesone, a nature identical compound found in plants of the family Myrtaceae that includes myrtles and eucalpyts; and
  • Qcide, derived from a natural oil product containing tasmanone extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk